Torque Teno Virus: A Biomarker of Immunosuppression in Kidney Transplantation, an Observational Single Centre Study

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY

To seek an association between Torque Teno Virus DNA titres resulting from under or over-immunosuppression in a kidney allograft recipient, Graft rejection, both cell-mediated rejection and antibody-mediated rejection, donor-specific antibodies (DSA), the incidence of BK viraemia and BK nephropathy, CMV infection or diseases and PCP infection and the number of circulating NK, B and T lymphocyte subtypes.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 16
Healthy Volunteers: f
View:

• All consenting renal transplant recipients in the study period will be included in the study

Locations
Other Locations
United Kingdom
Royal London Hospital
RECRUITING
London
Contact Information
Primary
Ramyangshu Chakraborty, MBBS
ramyangshu.chakraborty@nhs.net
07760781445
Time Frame
Start Date: 2022-02-15
Estimated Completion Date: 2026-03-31
Participants
Target number of participants: 400
Treatments
Renal transplant recipients
All incident renal transplant recipients after the commencement of the study
Sponsors
Leads: Queen Mary University of London

This content was sourced from clinicaltrials.gov